SuperworthAgilent Technologies profit margin A
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- 19.5%
- Operating margin, 12 months
- 22.2%
- Net margin on a year earlier
- +1.6 pts
- Peer median
- 12.6%
Over the twelve months to Jul 31, 2026, Agilent Technologies kept 19.5% of its revenue as net profit, with an operating margin of 22.2% and a gross margin of 53.8%.
Five years earlier its net margin was 16.1%.
The median for 10 diagnostics and research stocks of a similar size is 12.6%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 18.8% | 21.3% | 52.4% |
| FY2024 | 19.8% | 22.9% | 54.3% |
| FY2023 | 18.1% | 19.8% | 50.7% |
| FY2022 | 18.3% | 23.6% | 54.4% |
| FY2021 | 19.1% | 21.3% | 53.9% |
| FY2020 | 13.5% | 15.8% | 53.1% |
| FY2019 | 20.7% | 18.2% | 54.3% |
| FY2018 | 6.4% | 18.4% | 54.5% |
| FY2017 | 15.3% | 18.8% | 53.9% |
| FY2016 | 11.0% | 14.6% | 52.3% |
| FY2015 | 9.9% | 12.9% | 50.5% |
| FY2014 | 12.5% | 10.4% | 48.8% |
| FY2013 | 10.7% | 14.0% | 52.1% |
| FY2012 | 16.8% | 16.3% | 52.6% |
| FY2011 | 15.3% | 16.2% | 53.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q3 FY26 | 19.5% | +1.6 pts | 22.2% | |
| Q2 FY26 | 19.6% | +2.0 pts | 21.5% | |
| Q1 FY26 | 18.3% | −1.0 pts | 20.6% | |
| Q4 FY25 | 18.8% | −1.0 pts | 21.3% | |
| Q3 FY25 | 18.0% | −3.8 pts | 21.3% | |
| Q2 FY25 | 17.6% | −1.3 pts | 21.4% | |
| Q1 FY25 | 19.3% | +0.9 pts | 22.7% | |
| Q4 FY24 | 19.8% | +1.7 pts | 22.9% | |
| Q3 FY24 | 21.7% | +5.5 pts | 22.9% | |
| Q2 FY24 | 18.8% | −0.3 pts | 19.5% | |
| Q1 FY24 | 18.4% | −0.7 pts | 19.4% | |
| Q4 FY23 | 18.1% | −0.2 pts | 19.8% |
Against its peers
Companies in Medical - Diagnostics & Research nearest Agilent Technologies' size, closest first, today.
| Company | Profit margin |
|---|---|
| AAgilent Technologies | 19.5% |
| IQVIQVIA | 8.1% |
| WATWaters | 3.6% |
| IDXXIDEXX Laboratories | 25.0% |
| ILMNIllumina | 18.4% |
| MTDMettler-Toledo International | 21.9% |
| DGXQuest Diagnostics | 9.2% |
| LHLabcorp | 7.0% |
| MEDPMedpace | 17.7% |
| RVTYRevvity | 8.2% |
| DHRDanaher | 15.9% |
| Peer median | 12.6% |
Where Agilent Technologies ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Agilent Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.